MELANIE RATHKE: Open Payments
NPI 1760878508 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 29 payments from 13 companies in 2025. Trend: 2023 $457 · 2024 $375 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $173 |
| Pulmonx Corporation | 1 | $110 |
| Amgen Inc. | 5 | $75 |
| PFIZER INC. | 4 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Exeltis, USA Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: Ozempic, CHARTIS CATHETER, OTEZLA, NURTEC ODT, JARDIANCE, EVENITY, XIFAXAN, TZIELD.
Industry payments across AR — which companies pay providers there.
